Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

11/25/04 Reduced immunoglobulin E and allergy among adults with glioma compared with controls.        

11/25/04 SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival.        

11/25/04 Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.        

11/24/04 Survival benefit confirmed in patients with brain metastases from breast cancer        

11/24/04 Anti-Cancer Vaccine Doubles Time-To-Disease Progression and Increases Survival in Phase I Brain Cancer Trial        

11/23/04 Guilford Pharmaceuticals Inc. (GLFD) Presents New GLIADEL(R) Wafer Data At The Society For Neuro-Oncology Annual Meeting        

11/23/04 Dr. S. R. Burzynski Presents Preliminary Research On Antineoplastons A10 and AS2-1 For Treatment of Deadly Brain Tumors to the Society For Neuro-Oncology        

11/23/04 NEW AND UPDATED IL13-PE38QQR PHASE I/II DATA PRESENTED AT THE 9TH ANNUAL MEETING OF THE SOCIETY FOR NEURO-ONCOLOGY        

11/20/04 UMC Showcases Latest, Greatest Radiation Treatment        

11/19/04 Patient expectation is a strong predictor of severe nausea after chemotherapy        

11/19/04 Pharmacyclics Announces Presentation of Results From Two Phase 1 Clinical Trials Evaluating Xcytrin Plus Cranial Irradiation for Aggressive Brain Tumors        

11/19/04 Cancer stem cells the root cause for brain tumours :        

11/19/04 Chain letter scam making the rounds in Hermiston        

11/19/04 Positive Results Reported in Phase II Study of Cervene - TP-38 - To Treat Brain Cancer; Data Presented at Society for Neuro-Oncology Meeting in Toronto        

11/19/04 FDA Approves Tarceva- For Patients with Advanced Non-Small Cell Lung Cancer; Only Targeted EGFR Therapy Shown to Improve Survival in Advanced Non-Small Cell Lung Cancer        

11/16/04 Post-Therapy Damage Seen on MRI Scans of Medulloblastoma Patients Can Be Mistaken for New Tumors        

11/16/04 On-line flow cytometry for real-time surgical guidance.        

11/16/04 Erlotinib (Tarceva®) Produces Responses in Glioblastoma Multiforme        

11/15/04 Gala to benefit the Brain Tumor Society        

---

Displaying Stories 5010 to 5029 of 7812
Previous 20           Next 20